Clark Capital Management Group, Inc.
Institutional investor · Portfolio as of Q3 2020
Top Holdings308 positions
iShares iBoxx $ High Yield Corporate Bond ETF | 2.5M | $210.9M | 4.0% | $60.62 | +0.01% | 7 qtrssince 2019-Q1 | Increased 91 |
iShares Core S&P 500 ETF | 515,584 | $173.3M | 3.3% | $289.21 | +6.84% | 7 qtrssince 2019-Q1 | Increased 90 |
SPDR BBG BARC HIGH YIELD BND | 1.4M | $147.9M | 2.8% | $72.38 | +0.02% | 6 qtrssince 2019-Q2 | Increased 84 |
SPDR PORTFOLIO S&P 500 GROWTH ETF | 2.3M | $116.4M | 2.2% | $33.91 | +40.90% | 3 qtrssince 2020-Q1 | Decreased 0 |
Apple Inc | 980,707 | $113.6M | 2.1% | $46.70 | +140.34% | 7 qtrssince 2019-Q1 | Increased 83 |
Microsoft Corp | 407,068 | $85.6M | 1.6% | $110.94 | +80.31% | 7 qtrssince 2019-Q1 | Decreased 0 |
iShares Edge MSCI USA Momentum Factor ETF | 541,732 | $79.9M | 1.5% | $138.14 | +0.28% | 6 qtrssince 2019-Q2 | Increased 76 |
Comcast Corp | 1.7M | $77.6M | 1.5% | $31.41 | +13.35% | 7 qtrssince 2019-Q1 | Increased 62 |
Procter & Gamble Co/The | 533,837 | $74.2M | 1.4% | $91.43 | +30.49% | 7 qtrssince 2019-Q1 | Decreased 0 |
UnitedHealth Group Inc | 217,431 | $67.8M | 1.3% | $216.84 | +29.49% | 7 qtrssince 2019-Q1 | Decreased 0 |
JPMorgan Chase & Co | 701,601 | $67.5M | 1.3% | $87.20 | -5.27% | 7 qtrssince 2019-Q1 | Increased 47 |
Johnson & Johnson | 452,195 | $67.3M | 1.3% | $116.53 | +8.34% | 7 qtrssince 2019-Q1 | Increased 50 |
Morgan Stanley | 1.3M | $64.5M | 1.2% | $37.82 | +6.42% | 7 qtrssince 2019-Q1 | Decreased 0 |
BlackRock Inc | 112,292 | $63.3M | 1.2% | $445.02 | +10.02% | 3 qtrssince 2020-Q1 | Increased 50 |
Willis Towers Watson PLC | 300,497 | $62.8M | 1.2% | $174.82 | +11.07% | 4 qtrssince 2019-Q4 | Increased 54 |
Medtronic PLC | 580,761 | $60.4M | 1.1% | $82.23 | +7.78% | 6 qtrssince 2019-Q2 | Increased 61 |
Broadcom Inc | 145,394 | $53M | 1.0% | $26.76 | +20.77% | 7 qtrssince 2019-Q1 | Increased 46 |
Southern Co/The | 971,589 | $52.7M | 1.0% | $45.65 | -5.02% | 6 qtrssince 2019-Q2 | Decreased 0 |
| 210,951 | $50.2M | 0.9% | $178.13 | +23.41% | 7 qtrssince 2019-Q1 | Decreased 0 | |
Bristol-Myers Squibb Co | 795,978 | $48M | 0.9% | $41.52 | +16.49% | 7 qtrssince 2019-Q1 | Decreased 0 |
Clark Capital Management Group, Inc. manages $5.3B across 308 positions as of Q3 2020. Top holdings: HYG (4.0%), IVV (3.3%), JNK (2.8%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3.5/5.0.
Active quarter - 45 new positions, 34 exits, 102 increased. Top move: HYG (INCREASED, conviction 91). Portfolio: $5.3B across 308 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR